Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-26 @ 2:32 AM
Study NCT ID:
NCT00776802
Status:
WITHDRAWN
Last Update Posted:
2013-06-25
First Post:
2008-10-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
La Jolla Pharmaceutical Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-19
First Submit QC Date:
None
Study First Post Date:
2008-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-21
Last Update Post Date:
2013-06-25
Last Update Post Date Type:
ESTIMATED